Meet the Spaulding Clinical Leadership Team
Executives and subject matter experts
The People Leading You to the Next Milestone by Delivering Quality Data, Fast.
Cassandra Erato
CEO
Cassandra Erato’s comprehensive knowledge of Spaulding Clinical’s business and client base is driven by her depth of experience with the company — she joined at its inception in 2007 and was named CEO in 2020. She was previously in charge of all facets of daily operations as COO, and before that, director of clinical and biometrics operations, where she was responsible for study unit activities as well as back-end data management services related to the conduct of Spaulding’s clinical trials. She is a Nurse Practitioner with degrees in nursing from Marquette University.
Randy Spaulding
Founder, Chairman, Chief Visionary Officer
Randy Spaulding founded Spaulding Clinical in 2007 with the vision of a completely paperless, automated, and fully integrated research facility. As CEO, he grew the company to 100 employees, offering the most technologically advanced, fully automated research facility, with data quality unmatched by competitors. A board member of BioForward, Inc., and a Six Sigma Master Black Belt, Randy has a bachelor’s in biomedical engineering from Marquette University.
Dr. Jay Mason
Chief Medical Officer
Dr. Jay Mason brings 35+ years of experience to his role as Spaulding Clinical’s chief medical officer. He was previously CMO at OBS Medical, medical director at Covance, chairman of the University of Kentucky Department of Medicine, and chief of cardiology at University of Utah Hospitals and Clinics, where he has maintained a professorship for 37 years.
Lee Barsky
Vice President of Global Sales
Lee Barsky brings 25 years of clinical trials and pharmaceutical industry experience in both sales and operations to his role as vice president of global sales. PMP-certified with therapeutic experience in oncology, neurology, rheumatology, vaccines, and obstetrics/gynecology, Lee leads sales and marketing efforts at Spaulding Clinical. He spent 15 years in early-phase clinical research, running both large scale multicenter pivotal trials and smaller medical device trials from a sponsor and CRO prospective. He has a healthcare administration MBA from Almeda University and a bachelor’s from Temple University.